These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 217699)

  • 1. Mechanism of quasi-morphine withdrawal behaviour induced by methylxanthines.
    Butt NM; Collier HO; Cuthbert NJ; Francis DL; Saeed SA
    Eur J Pharmacol; 1979 Feb; 53(4):375-8. PubMed ID: 217699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Character and meaning of quasi-morphine withdrawal phenomena elicited by methylxanthines.
    Collier HO; Cuthbert NJ; Francis DL
    Fed Proc; 1981 Apr; 40(5):1513-8. PubMed ID: 6163662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphone abstinence and quasi-abstinence effects after phosphodiesterase inhibitors and naloxone.
    Francis DL; Roy AC; Collier HO
    Life Sci; 1975 Jun; 16(12):1901-6. PubMed ID: 168452
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds.
    Francis SH; Sekhar KR; Ke H; Corbin JD
    Handb Exp Pharmacol; 2011; (200):93-133. PubMed ID: 20859794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opiates, cyclic nucleotides, and xanthines.
    Collier HO; Francis DL; Roy AC
    Adv Biochem Psychopharmacol; 1976; 15():337-45. PubMed ID: 192053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 5'-nucleotidase in rat brain by methylxanthines.
    Tsuzuki J; Newburgh RW
    J Neurochem; 1975 Dec; 25(6):895-6. PubMed ID: 173803
    [No Abstract]   [Full Text] [Related]  

  • 7. Methylxanthine inhibitors of phosphodiesterases.
    Wells JN; Miller JR
    Methods Enzymol; 1988; 159():489-96. PubMed ID: 2457788
    [No Abstract]   [Full Text] [Related]  

  • 8. Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment.
    Wells JN; Kramer GL
    Mol Cell Endocrinol; 1981 Jul; 23(1):1-9. PubMed ID: 6167475
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
    Mushlin P; Boerth RC; Wells JN
    Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of the relationship between pharmacological inhibition of cyclic nucleotide phosphodiesterase and relaxation of canine tracheal smooth muscle.
    Polson JB; Krzanowski JJ; Anderson WH; Fitzpatrick DF; Hwang DP; Szentivanyi A
    Biochem Pharmacol; 1979 Apr; 28(8):1391-5. PubMed ID: 87201
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
    Nemoz G; Prigent AF
    Ann Pharm Fr; 1984; 42(2):99-112. PubMed ID: 6091520
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors.
    Glass WF; Moore JB
    Biochem Pharmacol; 1979 Apr; 28(7):1107-12. PubMed ID: 87197
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of four methylxanthine compounds and norepinephrine on cardiac phosphorylase activation and cardiac contractility.
    McNeill JH; Brenner MJ; Muschek LD
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():261-73. PubMed ID: 4377599
    [No Abstract]   [Full Text] [Related]  

  • 14. Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice.
    Bilbao A; Cippitelli A; Martín AB; Granado N; Ortiz O; Bezard E; Chen JF; Navarro M; Rodríguez de Fonseca F; Moratalla R
    Psychopharmacology (Berl); 2006 Apr; 185(2):160-8. PubMed ID: 16470403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
    Lavan BE; Lakey T; Houslay MD
    Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of different xanthines and phosphodiesterase inhibitors on c-fos expression in rat striatum.
    Svenningsson P; Johansson B; Fredholm BB
    Acta Physiol Scand; 1995 May; 154(1):17-24. PubMed ID: 7572198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of rat lung cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase by cyclic nucleotides and their analogues and various drugs [proceedings].
    Butt NM; Saeed SA; Collier HO
    Biochem Soc Trans; 1980 Jun; 8(3):380-1. PubMed ID: 6249674
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
    Ilien B; Ruckstuhl M; Landry Y
    J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do conventional plasma cyclic nucleotide phosphodiesterase inhibitors really work in all situations?
    Wood PJ; Pao G; Ross G; Smith C
    Clin Chim Acta; 1981 Sep; 115(3):405-8. PubMed ID: 6271425
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats.
    Sharma RV; Bhalla RC
    Biochim Biophys Acta; 1978 Oct; 526(2):479-88. PubMed ID: 214127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.